178 related articles for article (PubMed ID: 31753604)
1. Cribriform pattern and perineural invasion on MR/US fusion biopsy predict failure of selection criteria for prostatic hemigland ablation.
Mithal P; Truong M; Quarrier S; Lu D; Hollenberg G; Weinberg E; Miyamoto H; Frye T
Urol Oncol; 2020 Feb; 38(2):38.e1-38.e8. PubMed ID: 31753604
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Analysis of Cribriform Morphology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy Correlated with Radical Prostatectomy Specimens.
Truong M; Feng C; Hollenberg G; Weinberg E; Messing EM; Miyamoto H; Frye TP
J Urol; 2018 Jan; 199(1):106-113. PubMed ID: 28728994
[TBL] [Abstract][Full Text] [Related]
3. Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patients.
Bloom JB; Daneshvar MA; Lebastchi AH; Ahdoot M; Gold SA; Hale G; Mehralivand S; Sanford T; Valera V; Wood BJ; Choyke PL; Merino MJ; Turkbey B; Parnes HL; Pinto PA
Urol Oncol; 2021 Oct; 39(10):729.e1-729.e6. PubMed ID: 33736975
[TBL] [Abstract][Full Text] [Related]
4. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.
Nyarangi-Dix J; Wiesenfarth M; Bonekamp D; Hitthaler B; Schütz V; Dieffenbacher S; Mueller-Wolf M; Roth W; Stenzinger A; Duensing S; Roethke M; Teber D; Schlemmer HP; Hohenfellner M; Radtke JP
Eur Urol Focus; 2020 Nov; 6(6):1205-1212. PubMed ID: 30477971
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
[TBL] [Abstract][Full Text] [Related]
6. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.
Flood TA; Schieda N; Keefe DT; Breau RH; Morash C; Hogan K; Belanger EC; Mai KT; Robertson SJ
Virchows Arch; 2016 Sep; 469(3):313-9. PubMed ID: 27394432
[TBL] [Abstract][Full Text] [Related]
7. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
[TBL] [Abstract][Full Text] [Related]
8. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938
[TBL] [Abstract][Full Text] [Related]
9. Perineural invasion by prostate cancer on MR/US fusion targeted biopsy is associated with extraprostatic extension and early biochemical recurrence after radical prostatectomy.
Truong M; Rais-Bahrami S; Nix JW; Messing EM; Miyamoto H; Gordetsky JB
Hum Pathol; 2017 Aug; 66():206-211. PubMed ID: 28705708
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of Sampling PI-RADS 4-5 Index Lesions Alone by MRI-guided In-bore Biopsy in Biopsy-naive Patients Undergoing Radical Prostatectomy.
Kilic M; Vural M; Coskun B; Acar Ö; Saglican Y; Akpek S; Esen T
Eur Urol Focus; 2020 Mar; 6(2):249-254. PubMed ID: 31054811
[TBL] [Abstract][Full Text] [Related]
11. Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma.
Prendeville S; Gertner M; Maganti M; Pintilie M; Perlis N; Toi A; Evans AJ; Finelli A; van der Kwast TH; Ghai S
J Urol; 2018 Jul; 200(1):104-113. PubMed ID: 29408568
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
[TBL] [Abstract][Full Text] [Related]
13. Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer.
Choi YH; Yu JW; Kang MY; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
World J Urol; 2019 Oct; 37(10):2129-2135. PubMed ID: 30603783
[TBL] [Abstract][Full Text] [Related]
14. Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy.
Nassiri N; Chang E; Lieu P; Priester AM; Margolis DJA; Huang J; Reiter RE; Dorey FJ; Marks LS; Natarajan S
J Urol; 2018 Feb; 199(2):453-458. PubMed ID: 28830754
[TBL] [Abstract][Full Text] [Related]
15. Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance.
Ploussard G; Beauval JB; Lesourd M; Almeras C; Assoun J; Aziza R; Gautier JR; Loison G; Portalez D; Salin A; Tollon C; Soulié M; Malavaud B; Roumiguié M
World J Urol; 2020 Mar; 38(3):663-671. PubMed ID: 31197523
[TBL] [Abstract][Full Text] [Related]
16. Biopsy prostate cancer perineural invasion and tumour load are associated with positive posterolateral margins at radical prostatectomy: implications for planning of nerve-sparing surgery.
van der Slot MA; Remmers S; Kweldam CF; den Bakker MA; Nieboer D; Busstra MB; Gan M; Klaver S; Rietbergen JBW; van Leenders GJLH;
Histopathology; 2023 Sep; 83(3):348-356. PubMed ID: 37140551
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (Cribriform gleason pattern 4 and intraductal carcinoma): Correlation of detected and missed prostate cancer foci with whole mount histopathology.
Cai Q; Costa DN; Metter CK; Goldberg K; Roehrborn CG; Cadeddu J; Pedrosa I; Meng X; Mostardeiro TR; Shah RB
Urol Oncol; 2022 Oct; 40(10):452.e1-452.e8. PubMed ID: 36008255
[TBL] [Abstract][Full Text] [Related]
18. Performance of prostate multiparametric MRI for prediction of prostate cancer extra-prostatic extension according to NCCN risk categories: implication for surgical planning.
Falagario UG; Jambor I; Ratnani P; Martini A; Treacy PJ; Wajswol E; Lantz A; Papastefanou G; Weil R; Phillip D; Lewis S; Haines K; Cormio L; Carrieri G; Kyprianou N; Wiklund P; Tewari AK
Minerva Urol Nefrol; 2020 Dec; 72(6):746-754. PubMed ID: 32182231
[TBL] [Abstract][Full Text] [Related]
19. Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era?
Mazzone E; Stabile A; Sorce G; Pellegrino F; Barletta F; Motterle G; Scuderi S; Cirulli GO; Cucchiara V; Brembilla G; Esposito A; Gandaglia G; Fossati N; De Cobelli F; Montorsi F; Karnes RJ; Guccini I; Briganti A
Urol Oncol; 2021 Nov; 39(11):784.e1-784.e9. PubMed ID: 33865687
[TBL] [Abstract][Full Text] [Related]
20. Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.
Rayn KN; Bloom JB; Gold SA; Hale GR; Baiocco JA; Mehralivand S; Czarniecki M; Sabarwal VK; Valera V; Wood BJ; Merino MJ; Choyke P; Turkbey B; Pinto PA
J Urol; 2018 Nov; 200(5):1041-1047. PubMed ID: 29852182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
